4//SEC Filing
Worthington Mark 4
Accession 0001415889-25-006531
CIK 0001620463other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:28 PM ET
Size
8.2 KB
Accession
0001415889-25-006531
Insider Transaction Report
Form 4
Worthington Mark
General Counsel and CCO
Transactions
- Award
Stock Option (Right to Buy)
2025-03-03+85,895→ 85,895 totalExercise: $0.38Exp: 2035-03-02→ Common Stock (85,895 underlying) - Award
Restricted Stock Units
2025-03-03+57,263→ 57,263 total→ Common Stock (57,263 underlying)
Footnotes (3)
- [F1]The shares subject to the option shall be scheduled to vest monthly over a term of 48 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.
- [F3]100% of the RSUs shall vest on the one (1) year anniversary of the grant date, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan (the "Plan")) through the vesting date.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001861464
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:28 PM ET
- Size
- 8.2 KB